Works matching IS 20406207 AND DT 2018 AND VI 9 AND IP 10
Results: 2
The role of emicizumab, a bispecific factor IXa- and factor X-directed antibody, for the prevention of bleeding episodes in patients with hemophilia A.
- Published in:
- Therapeutic Advances in Hematology, 2018, v. 9, n. 10, p. 319, doi. 10.1177/2040620718799997
- By:
- Publication type:
- Article
Eltrombopag-based combination treatment for immune thrombocytopenia.
- Published in:
- Therapeutic Advances in Hematology, 2018, v. 9, n. 10, p. 309, doi. 10.1177/2040620718798798
- By:
- Publication type:
- Article